You are here

PB272

4 Top FDA Decisions Expected in Q1

24/7 Wall St

Mon, 01/4/16 - 10:05 am

Puma Biotechnology

Puma Biotechnology Announces Presentation of Positive PB272 Phase II Data at the 2014 ASCO Annual Meeting

Yahoo/BusinessWire

Sun, 06/1/14 - 11:33 am

Puma Biotechnology

HER2-positive metastatic breast cancer

Puma Biotechnology presents positive PB272 clinical data at ASCO

Yahoo/The Fly On The Wall

Sun, 06/3/12 - 11:07 am

Puma Biotechnology

Ex-Pfizer cancer drug shows mixed results in mid-stage studies

Fierce Biotech

Fri, 12/9/11 - 11:59 am

Puma Biotechnology